DRAXIS Chief Executive Officer Dr. Martin Barkin Named a Finalist for Ernst & Young Entrepreneur Of The Year? 2005 Award - Press Releases

DRAXIS Chief Executive Officer Dr. Martin Barkin Named a Finalist for Ernst & Young Entrepreneur Of The Year? 2005 Award
July 21, 2005
MISSISSAUGA, ONTARIO ? Dr. Martin Barkin, President and Chief Executive Officer of DRAXIS Health Inc. (TSX: DAX) (Nasdaq: DRAX), has been named a finalist for the Ernst & Young Entrepreneur Of The Year? 2005 awards. Dr. Barkin was selected by an independent judging panel as one of four finalists in the health sciences business category in the Qu?bec region.
The Entrepreneur Of The Year awards honour entrepreneurs who have demonstrated excellence and extraordinary success in areas such as innovation, risk taking, company development, financial performance and personal commitment to their businesses and communities. Submissions are reviewed by an independent judging panel, which is composed of several distinguished Canadian business leaders and previous award recipients.
"It is an honour to have DRAXIS recognized as a successful Canadian player in the health sciences field," said Dr. Barkin. "This nomination reflects the dedication, hard work and entrepreneurial spirit that our employees have demonstrated over the years and we are grateful to be acknowledged by Ernst & Young as a successful, growing specialty pharmaceutical company."
On October 25, 2005, a finalist in each business category will be presented with a regional category award during a gala celebration, with one category recipient then being awarded the title Entrepreneur Of The Year for the Qu?bec region. The Qu?bec Entrepreneur Of The Year will go on to compete with top entrepreneurs from the Pacific, Prairies, Ontario, and Atlantic regions for the coveted national honour of Canada's Entrepreneur Of The Year, to be announced November 3, 2005 in Ottawa. In May 2006, Canada's Entrepreneur Of The Year moves to the world stage, joining more than 35 country recipients participating in the international competition for the title of World Entrepreneur Of The Year.
About the Ernst & Young Entrepreneur Of The Year? Program
The Entrepreneur of the Year program was founded by Ernst & Young to celebrate great entrepreneurs and heighten awareness of the economic impact of entrepreneurial ventures. The program is nationally sponsored by Global Television Network, National Post, La Presse, RDI and Roynat Capital, together in Qu?bec with BMO Bank of Montreal, BMO Nesbitt Burns and Magazine PME. To learn more about the Ernst ? Young Entrepreneur of the Year 2005 awards, visit www.eoy.ca

About DRAXIS Health Inc.
DRAXIS Health is a specialty pharmaceutical company providing products in three categories. Sterile products include liquid and freeze-dried (lyophilized) injectables plus sterile ointments and creams. Non-sterile products are produced as solid oral and semi-solid dosage forms. Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are provided through the DRAXIS Pharma division and radiopharmaceuticals are developed, produced, and sold through the DRAXIMAGE division. DRAXIS Health employs over 500 staff in its Montreal facility.
About Ernst & Young
Ernst & Young, a global leader in professional services, is committed to restoring the public's trust in professional services firms and in the quality of financial reporting. Its 100,000 people in 140 countries pursue the highest levels of integrity, quality, and professionalism, providing a range of sophisticated services centred on our core competencies of auditing, accounting, tax, and transactions. Further information about Ernst & Young and its approach to a variety of business issues can be found at www.ey.com/perspectives. Ernst & Young refers to all the members of the global Ernst & Young organization.